Medical care for gender variant children and young people
Adult transsexual people often express the wish that they had received treatment when young. GIRES has prepared the publication below for the Department of Health. It can be dowloaded by clicking the image or ordered in printed form.
Use the menu to access other material in this section
Update May 2012
Since the publication of this booklet, the Tavistock Clinic in London has started providing hormone-blockers (gonadotrophin releasing hormone analogue, GnRHa) for carefully screened adolescents, to suspend their puberty, thus arresting the development of secondary sex characteristics. This treatment is provided under a research protocol and is reversible.
Update May 2011
The Tavistock Clinic in London, England, has obtained the ethical and other approvals required for its research into the suspension of puberty in gender variant adolescents. This will feature the same careful assessment of candidates for treatment as is applied by their Dutch colleagues. The Tavistock is due to start its research programme this month.
Previously, the treatment currently offered in the UK diverged markedly from that offered in other countries.
Update May 2010
Message from the clinicians who provide medical care for youngsters experiencing gender dysphoria at the Gender Identity Development Service (GIDS), in London, which is part ofthe Tavistock and Portman NHS Foundation Trust. They are now finalizing their research submission to commence a closely monitored programme of suspending the puberty of carefully screened adolescents, in whom the gender dysphoria is profound and highly likely to persist. This is subject to the approval of their research and ethics committees. However, this should not cause delay because these committees meet frequently. Polly Carmichael, who heads the London service is keen to get started.
Importantly it will be possible for the youngsters whose families have taken them to the USA for treatment to enter the GIDS programme as a separately monitored group.
The British Society for Paediatric Endocrinology and Diabetes (BSPED) has published its amended statement on caring for children and adolescents with gender identity disorder. This would allow the early suspension of puberty in adolescents, experiencing profound and persistent gender dysphoria, This safe and reversible treatment (a) prevents the development of unwanted secondary sex characterisitics, (b) relieves the related stress and (c) provides the young person and the involved clinicians with more time in which to decide on future physical interventions.
Search the site.